Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
hexasodium 5-({4-chloro-6-[{2-[(4-{[4-chloro-6-({8-hydroxy-3,6-disulfonato-7-[(4-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl)diazenyl]-1-naphthyl}amino)-1,3,5-triazin-2-yl]amino}phenyl)sulfonyl]ethyl}(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl}amino)-4-hydroxy-3-[(4-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl)diazenyl]naphthalene-2,7-disulfonate
EC number: 943-299-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute toxicity: via oral route
The harmonized LD50 cut-off valueof CR SB32N2 was 5000 mg/kg or Unclassified (OECD TG423).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From November 22, 2016 to June 06, 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- - Source: BioLASCO Taiwan Co., Ltd (Taipei, Taiwan)
- Age at study initiation: 9-10 week old
- Housing: one or two animals per cage
- Diet: ad libitum
- Water: ad libitum
- Photoperiod (hrs dark / hrs light): 12-hrs dark / 12-hrs light cycle - Route of administration:
- oral: gavage
- Vehicle:
- water
- Remarks:
- Water for injection (WFI)
- Doses:
- 2000 mg/kg b.w.
- No. of animals per sex per dose:
- three
- Sex:
- female
- Dose descriptor:
- LD50 cut-off
- Effect level:
- 5 000 mg/kg bw
- Based on:
- test mat.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- According to OECD 423 test method a, the harmonized LD50 cut-off value of CR SB32N2 was 5000 mg/kg. Therefore, CR SB32N2 was Category 5 or Unclassified based on GHS criteria.
- Executive summary:
This test using the procedures outlined in the QPS Taiwan Study Plan for T65316015-GN which is based on the SOP for the OECD 423 and OECD 423 (OECD, 2002). A total of 6 female Sprague-Dawley rats were orally dosed with CR SB32N2 in two dose steps of three animals each, at 2000 mg/kg b.w. for both Dose Step 1 and Dose Step 2. All animals in the two dose steps tolerated the test article well with increasing body weights and no mortality or moribundity reported. The remarkable clinical signs observed were excretion of deep pink feces in both dose steps on Dosing Day 1 and deep pink discoloration of the tail. Isolated instances of forelimb hair loss was also noted for one animal in Dose Step 2. In absence of mortality, moribund state, or other significant clinical and gross signs of toxicity, these results place CR SB32N2 in the GHS Category 5 or Unclassified, with harmonized LD50 cut-off value at 5,000 mg/kg or Unclassified.
Reference
Respectively, the mortalities andclinical observations in Dose Step 1 and 2 as below:
In Dose Step 1
No mortality occurred within the first three days post-dose. All dose animals tolerated the dose well and survived to termination on Day 15. Two animals (ID No. 0001 and 0003) were seen the excretion of feces of unusual color (deep pink), watery or unformed at 4 hours post dose. Animal ID No. 0001 also excreted watery brown feces at 0.5 hour post dose. Deep pink-stained skin over feet or tail was noted for all animal.
In Dose Step 2
All dose animals tolerated the dose well and survived to termination on Day 15. One animal (ID No. 0004) was seen the excretion of feces of unusual color (deep pink), watery or unformed was seen at 4 hours post dose. Deep pink-stained skin over feet or tail was noted for two animals (ID No. 0004 and 0005). Other observations include the hair loss of the forelimbs for one animal (ID No. 0006). The small amount of hair loss was first observed on Day 1 and persistent to study completion.
In Dose Step 1 and 2, body weights increased throughout the study period and gross examination at termination revealed no remarkable changes or lesions in all dose animals.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Quality of whole database:
- Limited exposure evisaged.
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- 2016
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Based on reliable review of literature and assessment of similar sulphonated azo dyes. No further animal testing is justified.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Principles of method if other than guideline:
- Methods not always explicit in reviews, but OECD testing principles appear to have been followed in most cases.
- GLP compliance:
- not specified
- Test type:
- other: Review of various studies
- Limit test:
- no
- Species:
- rat
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Mostly rat data, but dermal effects on guinea pigs and rabbits also examined (non-maximised sensitisation studies and dermal irritation)
- Type of coverage:
- not specified
- Vehicle:
- not specified
- Doses:
- Up to 2000 mg/kg
- Control animals:
- not specified
- Sex:
- male/female
- Dose descriptor:
- discriminating dose
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality reported
- Clinical signs:
- Other than discolouration, no clinical signs
- Gross pathology:
- No adverse systemic effects reported.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Based on reliable review of literature and assessment of similar sulphonated azo dyes.
No further animal testing is justified. - Executive summary:
From assessment of similar substances and substances containing the same groups, none are noted as being acutely toxic and there is no evidence of dermal absorption. From various data sources, it is considered unlikely that the substance will be acutely toxic by the dermal route. Most dyes of this class have acute toxicity discriminating dose > 2000 mg/kg and the similar substances reviewed fall into this category.
There is limited evidence that this type of substance is significantly absorbed by dermal contact due to the high molecular weight. Assessments of smaller molecules containing the same functional groups suggest low dermal toxicity.
It is not considered justifiable to perform further acute oral toxicity testing on CR SB32N2 in view of the similarity with other dyes assessed in this report.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- This class of substance considered to be of low toxicity and not likely to be absorbed dermally.
Additional information
Acute toxicity: via oral route
A total of 6 female Sprague-Dawley rats were orally dosed with CR SB32N2 in two dose steps of three animals each, at 2000 mg/kg b.w. for both Dose Step 1 and Dose Step 2. All animals in the two dose steps tolerated the test article well with increasing body weights and no mortality or moribundity reported. The remarkable clinical signs observed were excretion of deep pink feces in both dose steps on Dosing Day 1 and deep pink discoloration of the tail. Isolated instances of forelimb hair loss was also noted for one animal in Dose Step 2. In absence of mortality, moribund state, or other significant clinical and gross signs of toxicity, these results place CR SB32N2 in the GHS Category 5 or Unclassified, with harmonized LD50 cut-off value at 5,000 mg/kg or Unclassified.
Acute dermal toxicity
From assessment of similar substances and substances containing the same groups, none are noted as being acutely toxic and there is no evidence of dermal absorption. From various data sources, it is considered unlikely that the substance will be acutely toxic by the dermal route. Most dyes of this class have acute toxicity discriminating dose > 2000 mg/kg and the similar substances reviewed fall into this category.
There is limited evidence that this type of substance is significantly absorbed by dermal contact due to the high molecular weight. Assessments of smaller molecules containing the same functional groups suggest low dermal toxicity.
It is not considered justifiable to perform further acute oral toxicity testing on CR SB32N2 in view of the similarity with other dyes assessed in this report.
Justification for selection of acute toxicity – dermal endpoint
Based on reliable review of literature and assessment of similar sulphonated azo dyes.
No further animal testing is justified.
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.